The rationale for early postoperative intraperitoneal chemotherapy for gastric cancer.
W J
WJ
Cunliffe
D017024:Chemotherapy, Adjuvant / Q000379:methods; D002945:Cisplatin / Q000493:pharmacokinetics / Q000627:therapeutic use; D004317:Doxorubicin / Q000493:pharmacokinetics / Q000627:therapeutic use; D004341:Drug Evaluation; D005472:Fluorouracil / Q000493:pharmacokinetics / Q000627:therapeutic use; D006801:Humans; D007263:Infusions, Parenteral / Q000009:adverse effects / Q000379:methods; D016685:Mitomycin / Q000493:pharmacokinetics / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D013274:Stomach Neoplasms / Q000150:complications / Q000188:drug therapy*
D016685:Mitomycin; D004317:Doxorubicin; D002945:Cisplatin; D005472:Fluorouracil